Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bio-Techne Corp (TECH)

Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

What to Expect From Bio-Techne's Q3 2026 Earnings Report

Minneapolis, Minnesota-based Bio-Techne Corporation (TECH) develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company has a market cap of $9 billion and operates through two segments: Protein Sciences, Diagnostics and Spatial Biology.

TECH is expected to release its Q3 2026 earnings on Wednesday, May 6, before the market opens. Ahead of the event, analysts expect the company’s EPS to be $0.48 on a diluted basis, down 4% from $0.50 in the year-ago quarter. The company has met or exceeded Wall Street’s EPS estimates in each of its last four quarters.

Fundamentals

See More
  • Market Capitalization, $K 9,266,711
  • Shares Outstanding, K 156,453
  • Annual Sales, $ 1,220 M
  • Annual Income, $ 73,400 K
  • EBIT $ 117 M
  • EBITDA $ 227 M
  • 60-Month Beta 1.49
  • Price/Sales 7.36
  • Price/Cash Flow 23.46
  • Price/Book 4.46

Options Overview Details

View History
  • Implied Volatility 54.49% (-1.19%)
  • Historical Volatility 35.79%
  • IV Percentile 82%
  • IV Rank 64.42%
  • IV High 64.28% on 04/30/25
  • IV Low 36.75% on 09/16/25
  • Expected Move (DTE 26) 6.23 (10.52%)
  • Put/Call Vol Ratio 0.45
  • Today's Volume 32
  • Volume Avg (30-Day) 1,653
  • Put/Call OI Ratio 2.33
  • Today's Open Interest 39,877
  • Open Int (30-Day) 35,752
  • Expected Range 53.00 to 65.46

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.48
  • Number of Estimates 6
  • High Estimate $0.51
  • Low Estimate $0.40
  • Prior Year $0.50
  • Growth Rate Est. (year over year) -4.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.53 +19.60%
on 03/18/26
60.44 -2.00%
on 04/14/26
+8.17 (+16.00%)
since 03/17/26
3-Month
48.25 +22.76%
on 03/16/26
72.16 -17.92%
on 01/22/26
-9.44 (-13.75%)
since 01/16/26
52-Week
46.01 +28.73%
on 04/21/25
72.16 -17.92%
on 01/22/26
+11.13 (+23.14%)
since 04/17/25

Most Recent Stories

More News
Revvity, Bio-Techne, Corcept, Supernus Pharmaceuticals, and Phibro Animal Health Shares Skyrocket, What You Need To Know

Revvity, Bio-Techne, Corcept, Supernus Pharmaceuticals, and Phibro Animal Health Shares Skyrocket, What You Need To Know

TECH : 59.23 (+3.26%)
CORT : 46.16 (+5.00%)
SUPN : 51.39 (+4.41%)
PAHC : 57.07 (+5.92%)
RVTY : 93.96 (+5.03%)
What to Expect From Bio-Techne's Q3 2026 Earnings Report

Bio-Techne is set to announce its third-quarter earnings next month, and Wall Street expects the company’s EPS to decrease by a single digit.

TECH : 59.23 (+3.26%)
XLV : 148.80 (+1.49%)
$SPX : 7,126.06 (+1.20%)
Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity

MINNEAPOLIS , April 16, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science research tools, analytical instruments, and diagnostics, today announced a streamlined...

TECH : 59.23 (+3.26%)
Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity

MINNEAPOLIS , April 16, 2026 /CNW/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science research tools, analytical instruments, and diagnostics, today announced a streamlined...

TECH : 59.23 (+3.26%)
Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results

MINNEAPOLIS , April 14, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, May 6, 2026, at 8:00 a.m....

TECH : 59.23 (+3.26%)
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know

CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know

TECH : 59.23 (+3.26%)
BRKR : 40.70 (+4.52%)
WAT : 327.77 (+2.74%)
CNMD : 39.08 (+3.09%)
AVTR : 8.52 (+3.15%)
Q4 Research Tools & Consumables Earnings: Bio-Techne (NASDAQ:TECH) Earns Top Marks

Q4 Research Tools & Consumables Earnings: Bio-Techne (NASDAQ:TECH) Earns Top Marks

TECH : 59.23 (+3.26%)
Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite

MINNEAPOLIS , March 25, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced the expansion of...

TECH : 59.23 (+3.26%)
How Is Bio-Techne's Stock Performance Compared to Other Biotechnology Stocks

Bio-Techne has underperformed other biotechnology stocks over the past year, yet analysts remain moderately optimistic about the stock’s growth potential.

TECH : 59.23 (+3.26%)
BBIO : 76.75 (-0.98%)
XBI : 138.67 (+2.37%)
3 Cash-Producing Stocks with Open Questions

3 Cash-Producing Stocks with Open Questions

TECH : 59.23 (+3.26%)
KHC : 22.47 (-0.53%)
HIMX : 11.10 (-1.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising...

See More

Key Turning Points

3rd Resistance Point 61.74
2nd Resistance Point 60.84
1st Resistance Point 60.04
Last Price 59.23
1st Support Level 58.34
2nd Support Level 57.44
3rd Support Level 56.64

See More

52-Week High 72.16
Fibonacci 61.8% 62.17
Last Price 59.23
Fibonacci 50% 59.08
Fibonacci 38.2% 56.00
52-Week Low 46.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.